Emergent BioSolutions Inc.EBSNYSE
Loading
Operating Expenses Over TimeContracting
Percentile Rank57
3Y CAGR-28.0%
5Y CAGR-10.8%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-28.0%/yr
vs +29.2%/yr prior
5Y CAGR
-10.8%/yr
Recent deceleration
Acceleration
-57.2pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $240.40M | -50.3% |
| 2024 | $484.10M | -55.4% |
| 2023 | $1.09B | +69.0% |
| 2022 | $643.00M | +42.3% |
| 2021 | $451.80M | +6.4% |
| 2020 | $424.60M | +15.1% |
| 2019 | $369.00M | +60.0% |
| 2018 | $230.60M | +44.8% |
| 2017 | $159.30M | +14.4% |
| 2016 | $139.30M | - |